MedTrace Logo

Microcirculatory Changes During Magnesium Sulphate Infusion in Sepsis

NCT01332734 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2011-04-11

No results posted yet for this study

Summary

During infections (sepsis) bloodflow in small vessels (microcirculation) becomes disturbed. Restoration of bloodpressure and cardiac performance may not be sufficient to correct these alterations. Magnesium is a potent vasodilator which may be used to open up the small vessels, in order to reduce organ failure.

Conditions

  • Severe Sepsis
  • Septic Shock

Interventions

DRUG

Magnesium Sulfate

2 gram in 1 hour

Sponsors & Collaborators

  • Lithuanian University of Health Sciences

    collaborator OTHER

  • Frisius Medisch Centrum

    lead OTHER

Principal Investigators

  • A Pranskunas, MD · Lithuanian university of sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-08-31
Completion
2011-01-31

Countries

  • Lithuania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01332734 on ClinicalTrials.gov